- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
E-cadherin (CDH1) is a calcium-dependent transmembrane glycoprotein that functions as a key tumor suppressor and central regulator of epithelial cell-cell adhesion. E-cadherin (CDH1) antibody, also known as Cadherin 1 antibody, detects a protein that maintains epithelial integrity and prevents loss of tissue organization. E-cadherin Antibody / Tumor Suppression and EMT Marker Antibody (clone CDH1/9615R) enables detection of this protein in studies focused on epithelial-to-mesenchymal transition and cancer progression.
CDH1 plays a critical role in suppressing tumor invasion by maintaining stable cell-cell adhesion within epithelial tissues. Loss or downregulation of E-cadherin is a hallmark of epithelial-to-mesenchymal transition, a process in which epithelial cells lose adhesion, gain migratory capacity, and adopt a more invasive phenotype. Detection of E-cadherin is therefore widely used to distinguish epithelial and mesenchymal states and to evaluate tumor progression across a range of cancer types.
In cancer biology, reduced CDH1 expression is associated with increased invasiveness, metastasis, and poor clinical outcomes in epithelial-derived tumors such as breast, gastric, and colorectal carcinomas. Conversely, preserved E-cadherin expression supports epithelial differentiation and organized tissue structure. E-cadherin Antibody provides a direct readout of these biological states and is commonly used to assess tumor phenotype and progression.
At the molecular level, E-cadherin interacts with catenins and cytoskeletal components to regulate both adhesion and intracellular signaling pathways. These interactions influence key processes including proliferation, differentiation, and cell survival. Disruption of CDH1-mediated adhesion can alter these pathways and contribute to tumor development and progression.
The recombinant mouse monoclonal clone CDH1/9615R antibody provides consistent detection of E-cadherin and is well suited for studies focused on tumor biology, EMT, and epithelial differentiation. This E-cadherin antibody supports investigation of cancer-related changes in adhesion and provides a valuable tool for analyzing epithelial integrity in disease contexts.
This antibody is part of the CDH1 antibody collection, where multiple E-cadherin antibody formats and applications are available for studying epithelial adhesion and cancer progression.
Optimal dilution of the E-cadherin Antibody / Tumor Suppression and EMT Marker Antibody should be determined by the researcher.
Recombinant full-length human Cadherin 1 protein was used as the immunogen for the recombinant E-Cadherin antibody.
Aliquot the recombinant E-Cadherin antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
CDH1 antibody, E-cadherin antibody, Cadherin 1 EMT marker antibody, epithelial to mesenchymal transition antibody, tumor suppression marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.